Antiviral drug development presents a unique set of challenges. First, viruses are constantly mutating, and drug-resistant viruses emerge easily. Therefore, combination therapies are typically required to maintain a sustained virologic response. In addition, successful treatment requires high medication adherence, which is often a challenge for patients with chronic viral infections such as hepatitis or HIV. […]
Read MoreSimulating Viral Dynamics in the New Trial Simulator
0 comments.
Click here to read/write comments.
Topics:
PK/PD Modeling & Simulation